LOADING
Comparing Comcast Corporation (CMCSA) and Pfizer Inc (PFE) across the Communication Services and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | CMCSA | PFE |
|---|---|---|
| Price | $26.85 | $28.07 |
| Change Today | +1.63% | +1.01% |
| Market Cap | $95.3B | $160.0B |
| P/E Ratio | 8.6 | 36.9 |
| Forward P/E | 7.7 | 9.5 |
| PEG Ratio | 2.39 | 2.72 |
| EPS | $3.12 | $0.76 |
| Revenue Growth (YoY) | -1.2% | 2.6% |
| Profit Margin | 9.0% | 6.8% |
| Return on Equity | 11.5% | 5.0% |
| Dividend Yield | 5.00% | 6.19% |
| Beta | 0.65 | 0.28 |
| 52-Week High | $32.05 | $28.44 |
| 52-Week Low | $21.28 | $22.03 |
| Volume | 20.3M | 37.1M |
Pfizer Inc is the larger company by market capitalization. Comcast Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Comcast Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.